Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Kobayashi Website

Hisataka Kobayashi, M.D., Ph.D.

Selected Publications

1)  Harada T, Sano K, Sato K, Watanabe R, Yu Z, Hanaoka H, Nakajima T, Choyke PL, Ptaszek M, Kobayashi H.
Activatable organic near-infrared fluorescent probes based on a bacteriochlorin platform: synthesis and multicolor in vivo imaging with a single excitation.
Bioconjug. Chem. 25: 362-9, 2014.
2)  Longmire MR, Ogawa M, Choyke PL, Kobayashi H.
Dendrimers as high relaxivity MR contrast agents.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 6: 155-62, 2014.
3)  Nakajima T, Sano K, Sato K, Watanabe R, Harada T, Hanaoka H, Choyke PL, Kobayashi H.
Fluorescence-lifetime molecular imaging can detect invisible peritoneal ovarian tumors in bloody ascites.
Cancer Sci. 105: 308-14, 2014.
4)  Turkbey B, Kobayashi H, Hoyt RF, Choyke PL, Nakajima T, Griffiths GL, Bernardo M, Rialon K, Fishman SJ, Sena LM.
Magnetic Resonance Lymphography of the Thoracic Duct after Interstitial Injection of Gadofosveset Trisodium: A Pilot Dosing Study in a Porcine Model.
Lymphat Res Biol. 2014.
5)  Sato K, Watanabe R, Hanaoka H, Harada T, Nakajima T, Kim I, Paik CH, Choyke PL, Kobayashi H.
Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Mol Oncol. 2014.
6)  Sano K, Nakajima T, Choyke PL, Kobayashi H.
The effect of photoimmunotherapy followed by liposomal daunorubicin in a mixed tumor model: a demonstration of the super-enhanced permeability and retention effect after photoimmunotherapy.
Mol. Cancer Ther. 13: 426-32, 2014.
7)  Sano K, Nakajima T, Ali T, Bartlett DW, Wu AM, Kim I, Paik CH, Choyke PL, Kobayashi H.
Activatable fluorescent cys-diabody conjugated with indocyanine green derivative: consideration of fluorescent catabolite kinetics on molecular imaging.
J Biomed Opt. 18: 101304, 2013.
8)  Ali T, Choyke PL, Kobayashi H.
Endoscopic molecular imaging of cancer.
Future Oncol. 9: 1501-13, 2013.
9)  Alexander VM, Choyke PL, Kobayashi H.
Fluorescent molecular imaging: technical progress and current preclinical and clinical applications in urogynecologic diseases.
Curr. Mol. Med. 13: 1568-78, 2013.
10)  Kobayashi H, Watanabe R, Choyke PL.
Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?.
Theranostics. 4: 81-9, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 3/18/2014.